Amphastar Pharmaceuticals AMPH Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amphastar Pharmaceuticals's cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Amphastar Pharmaceuticals's cash ratio?
- Amphastar Pharmaceuticals (AMPH) reported cash ratio of 1× in Q1 2026.
- How has Amphastar Pharmaceuticals's cash ratio changed year-over-year?
- Amphastar Pharmaceuticals's cash ratio increased by 13.2% year-over-year, from 0.9× to 1×.
- What is the long-term trend for Amphastar Pharmaceuticals's cash ratio?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's cash ratio has grown at a 5.4% compound annual growth rate (CAGR), from 0.8× to 1.1×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.